| 1 |
Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art [J]. Nat Rev Gastroenterol Hepatol, 2017, 14(3): 160-169.
|
| 2 |
Welbourn R, Hollyman M, Kinsman R, et al. Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Fourth IFSO Global Registry Report 2018 [J]. Obes Surg, 2019, 29(3): 782-795.
|
| 3 |
Mohapatra S, Gangadharan K, Pitchumoni CS. Malnutrition in obesity before and after bariatric surgery [J]. Dis Mon, 2020, 66(2): 100866.
|
| 4 |
Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity [J]. Lancet, 1982, 1(8265): 198-199.
|
| 5 |
Imaz I, Martínez-Cervell C, García-Alvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis [J]. Obes Surg, 2008, 18(7): 841-846.
|
| 6 |
Genco A, Bruni T, Doldi SB, et al. BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients [J]. Obes Surg, 2005, 15(8): 1161-1164.
|
| 7 |
Kotzampassi K, Grosomanidis V, Papakostas P, et al. 500 intragastric balloons: what happens 5 years thereafter? [J]. Obes Surg, 2012, 22(6): 896-903.
|
| 8 |
Ponce J, Woodman G, Swain J, et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity [J]. Surg Obes Relat Dis, 2015, 11(4): 874-881.
|
| 9 |
Marinos G, Eliades C, Raman Muthusamy V, et al. Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study [J]. Surg Obes Relate Dis, 2014, 10(5): 929-934.
|
| 10 |
Thompson CC, Abu Dayyeh BK, Kushner R, et al. Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial [J]. Am J Gastroenterol, 2017, 112(3): 447-457.
|
| 11 |
Thompson CC, Abu Dayyeh BK, Kushnir V, et al. Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial [J]. Surg Obes Relat Dis, 2019, 15(8): 1348-1354.
|
| 12 |
Fogel R, De Fogel J, Bonilla Y, et al. Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients [J]. Gastrointest Endosc, 2008, 68(1): 51-58.
|
| 13 |
Brethauer SA, Chand B, Schauer PR, et al. Transoral gastric volume reduction as intervention for weight management: 12-month follow-up of TRIM trial [J]. Surg Obes Relat Dis, 2012, 8(3): 296-303.
|
| 14 |
Kumar N, Abu Dayyeh BK, Lopez-Nava Breviere G, et al. Endoscopic sutured gastroplasty: procedure evolution from first-in-man cases through current technique [J]. Surg Endosc, 2018, 32(4): 2159-2164.
|
| 15 |
Abu Dayyeh BK, Acosta A, Camilleri M, et al. Endoscopic Sleeve Gastroplasty Alters Gastric Physiology and Induces Loss of Body Weight in Obese Individuals [J]. Clin Gastroenterol Hepatol, 2017, 15(1): 37-43.
|
| 16 |
Lopez-Nava G, Galvao M, Bautista-Castaño I, et al. Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success [J]. Endosc Int Open, 2016, 4(2): E222-227.
|
| 17 |
Lopez-Nava G, Sharaiha RZ, Vargas EJ, et al. Endoscopic Sleeve Gastroplasty for Obesity: a Multicenter Study of 248 Patients with 24 Months Follow-Up [J]. Obes Surg, 2017, 27(10): 2649-2655.
|
| 18 |
Espinós JC, Turró R, Mata A, et al. Early experience with the Incisionless Operating Platform™ (IOP) for the treatment of obesity: the Primary Obesity Surgery Endolumenal (POSE) procedure [J]. Obes Surg, 2013, 23(9): 1375-1383.
|
| 19 |
López-Nava G, Bautista-Castaño I, Jimenez A, et al. The Primary Obesity Surgery Endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes [J]. Surg Obes Relat Dis, 2015, 11(4): 861-865.
|
| 20 |
Verlaan T, Paulus GF, Mathus-Vliegen EM, et al. Endoscopic gastric volume reduction with a novel articulating plication device is safe and effective in the treatment of obesity (with video) [J]. Gastrointest Endosc, 2015, 81(2): 312-320.
|
| 21 |
Devière J, Ojeda Valdes G, Cuevas Herrera L, et al. Safety, feasibility and weight loss after transoral gastroplasty: First human multicenter study [J]. Surg Endosc, 2008, 22(3): 589-598.
|
| 22 |
Moreno C, Closset J, Dugardeyn S, et al. Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study [J]. Endoscopy, 2008, 40(5): 406-413.
|
| 23 |
Nanni G, Familiari P, Mor A, et al. Effectiveness of the Transoral Endoscopic Vertical Gastroplasty (TOGa®): a good balance between weight loss and complications, if compared with gastric bypass and biliopancreatic diversion [J]. Obes Surg, 2012, 22(12): 1897-1902.
|
| 24 |
de Jong K, Mathus-Vliegen EM, Veldhuyzen EA, et al. Short-term safety and efficacy of the Trans-oral Endoscopic Restrictive Implant System for the treatment of obesity [J]. Gastrointest Endosc, 2010, 72(3): 497-504.
|
| 25 |
Vilarrasa N, de Gordejuela AG, Casajoana A, et al. Endobarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism [J]. Obes Surg, 2017, 27(3): 569-577.
|
| 26 |
Koehestanie P, Dogan K, Berends F, et al. Duodenal-jejunal bypass liner implantation provokes rapid weight loss and improved glycemic control, accompanied by elevated fasting ghrelin levels [J]. Endosc Int Open, 2014, 2(1): E21-27.
|
| 27 |
Zechmeister-Koss I, Huić M, Fischer S. The duodenal-jejunal bypass liner for the treatment of type 2 diabetes mellitus and/or obesity: a systematic review [J]. Obes Surg, 2014, 24(2): 310-323.
|
| 28 |
Rajagopalan H, Cherrington AD, Thompson CC, et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in human proof-of-concept study [J]. Diabetes Care, 2016, 39(12): 2254-2261.
|
| 29 |
van Baar ACG, Holleman F, Crenier L, et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study [J]. Gut, 2020, 69(2): 295-303.
|
| 30 |
Sandler BJ, Rumbaut R, Swain CP, et al. Human experience with an endoluminal, endoscopic, gastrojejunal bypass sleeve [J]. Surg Endosc, 2011, 25(9): 3028-3033.
|
| 31 |
Sandler BJ, Rumbaut R, Swain CP, et al. One-year human experience with a novel endoluminal, endoscopic gastric bypass sleeve for morbid obesity [J]. Surg Endosc, 2015, 29(11): 3298-3303.
|
| 32 |
Ryou M, Aihara H, Thompson CC. Minimally invasive entero-enteral dual-path bypass using self-assembling magnets [J]. Surg Endosc, 2016, 30(10): 4533-4538.
|